Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Disulfide bonds typically introduce conformational constraints into peptides and proteins, conferring improved biopharmaceutical properties and greater therapeutic potential. In our opinion, disulfide-rich microdomains from proteins are potentially a rich and under-explored source of drug leads. A survey of the UniProt protein database shows that these domains are widely distributed throughout the plant and animal kingdoms, with the EGF-like domain being the most abundant of these domains. EGF-like domains exhibit large diversity in their disulfide bond topologies and calcium binding modes, which we classify in detail here. We found that many EGF-like domains are associated with disease phenotypes, and the interactions they mediate are potential therapeutic targets. Indeed, EGF-based therapeutic leads have been identified, and we further propose that these domains can be optimized to expand their therapeutic potential using chemical design strategies. This Review highlights the potential of disulfide-rich microdomains as future peptide therapeutics. © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Citation

Benjamin J Tombling, Conan K Wang, David J Craik. EGF-like and Other Disulfide-rich Microdomains as Therapeutic Scaffolds. Angewandte Chemie (International ed. in English). 2020 Jul 06;59(28):11218-11232

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 31867866

View Full Text